Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial (Sept, 10.1038/s41591-023-02572-5, 2023)Roch Houot,Emmanuel Bachy,Guillaume Cartron,Francois-Xavier Gros,Franck Morschhauser,Lucie Oberic,Thomas Gastinne,Pierre Feugier,Remy Dulery,Catherine Thieblemont,Magalie Joris,Fabrice Jardin,Sylvain Choquet,Olivier Casasnovas,Gabriel Brisou,Morgane Cheminant,Jacques-Olivier Bay,Francisco Llamas Gutierrez,Cedric Menard,Karin Tarte,Marie-Helene Delfau, Cedric Portugues,Emmanuel Itti,Xavier Palard-Novello,Paul Blanc-Durand, Yassine Al Tabaa,Clement Bailly,Camille Laurent,Francois LemonnierNATURE MEDICINE（2023）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
